My extensive experience over more than three decades in the healthcare sector has exposed me to numerous initiatives aimed at reforming an often malfunctioning system. The journey has been filled with both promising ideas and less successful attempts, particularly at the national, regional, and local levels. During my tenure on the Board of Trustees at
Health
The field of neuroscience has found itself embroiled in controversy following the recent revelations concerning Dr. Eliezer Masliah, a prominent figure in the National Institute on Aging’s (NIA) neuroscience division. The National Institutes of Health (NIH) announced on a Thursday that it discovered substantial evidence of research misconduct associated with Dr. Masliah, who had been
Hemophilia B, a genetic bleeding disorder caused by a deficiency in factor IX, presents significant management challenges for those affected. Traditionally, individuals with hemophilia B rely on prophylactic factor IX replacement therapies administered intravenously. While these treatments have been a cornerstone of management, they do not offer a permanent solution, nor do they prevent the